Bart Leroy

Head of Department of Ophthalmology, Ghent University Hospital, Professor of Ophthalmology, Ghent, Belgium; Director of the Ophthalmic Genetics and Retinal Degenerations clinics in the Division of Ophthalmology and Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia (CHOP).

Dr. Leroy, MD, Ph.D., is an expert in ophthalmic medicine and retinal degeneration, and is Professor of Ophthalmology at Ghent University, having been the Head of Department at Ghent University Hospital’s Department of Ophthalmology since 2016. Ghent was also where he completed his Ph.D. on inherited retinal dystrophies in 2006 after training as a clinical geneticist and ophthalmologist at Ghent University Hospital, and his fellowship at Moorfields Eye Hospital and the Institute of Ophthalmology, University College London, London, UK.

His clinical focus at both Ghent University Hospital and Children’s Hospital of Philadelphia is on the diagnosis and treatment of patients with inherited retinal and eye diseases including Leber congenital amaurosis, Stargardt disease, retinitis pigmentosa, and other genetic syndromes and diseases. He took part in the development of Luxturna and is currently involved in several clinical trials of ocular gene therapy. Dr. Leroy has authored over 150 papers, and received numerous prizes and grants for his work into ophthalmic medicine and retinal diseases.